SETD1B and cancer: KMT2E, for example, has been linked to greater cell resistance to fluorouracil (a medication used to treat malignancies of the stomach, colon, esophagus, rectal, and liver), while KMT2G has been linked to enhanced cell sensitivity to the same drug.